|
CBIO Crescent Biopharma Inc 1253689 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-24,837,000.00 |
| Balance Sheet |
|
Current Assets
|
$179,006,000.00 |
|
Assets
|
$182,758,000.00 |
|
Current Liabilities
|
$18,537,000.00 |
|
Liabilities
|
$19,503,000.00 |
|
Equity
|
$163,255,000.00 |
|
Shares Out
|
27756044.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-28,400,000.00 |
|
Investing Cash Flow
|
$-6,390,000.00 |
| Market Analysis |
Market Cap
|
$450,480,594.12 |
|
Price
|
$16.23 |
|
BVPS
|
5.88 |
|
PB
|
2.76 |
|
EPS
|
-0.04 |
|
PS
|
113.38 |
|
FCF
|
$-28,560,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:30 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CBIO documents filed with the SEC.
CBIO Filings
Clear
